ClinicalTrials.Veeva

Menu

Temporomandibular Dysfunction in Patients With Tinnitus: Assessment and Treatment

U

Universiteit Antwerpen

Status

Completed

Conditions

Tinnitus, Subjective

Treatments

Other: TMD treatment: physiotherapy and/or occlusal splints

Study type

Interventional

Funder types

Other

Identifiers

NCT03209297
T001916N

Details and patient eligibility

About

TMD treatment, based on state of the art knowledge derived from clinical studies will be applied in patients with tinnitus and TMD. When this approach proves to be useful for the treatment of tinnitus, it offers a new therapeutic option for patients with tinnitus. To understand how TMD treatment works for patients with tinnitus, we will analyse mediating factors, i.e. factors that contribute to the therapeutic effect. To help clinicians in their clinical process we will identify prognostic indicators, i.e. factors that predict a positive or negative outcome of TMD treatment. This can provide a helpful tool in clinical practice.

Enrollment

120 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients will be included when suffering from somatic tinnitus, attributed to TMD, which has been stable for at least 3 months.
  • Tinnitus Functional Index score between 25 and 90

Exclusion criteria

  • clear otological or neurological causes of the tinnitus such as Menière's disease, severe depression (diagnosed by a psychologist), progressive middle ear pathology, intracranial pathology
  • traumatic cervical spine or temporomandibular injury in the past 6 months
  • tumours
  • previous surgery in the orofacial area
  • in case physical therapy treatment directed to the orofacial area is contra-indicated
  • if the patient received TMD treatment in the past 2 months
  • drug intake that can affect the outcome measures

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

120 participants in 2 patient groups

Direct treatment
Experimental group
Description:
Patients receive the TMD treatment immediately
Treatment:
Other: TMD treatment: physiotherapy and/or occlusal splints
Delayed treatment
Experimental group
Description:
No intervention in the first 9 weeks of the study. Afterwards, the patients receive the same treatment as the other group
Treatment:
Other: TMD treatment: physiotherapy and/or occlusal splints

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems